Clinigen en las noticias
Acceso ético global a medicamentos
Tamtam encontró 13 artículos recientes sobre Clinigen.
- Clinigen Appoints Greg Skalicky as Chief Executive Officer
- Clinigen exec on the human side of patient access
- Shaun Chilton to take over as Chief Executive at Clinigen
- Amulet Capital Sells SSI Strategy To Clinigen
- Clinigen to Acquire SSI Strategy
- Acquisition of SSI Strategy by Clinigen
- Clinigen divests Proleukin® to Iovance Biotherapeutics for £166.7 million
- White & Case Advises Triton on £1.2 Billion Recommended Takeover of Clinigen Group plc
- Secura Bio Announces European Distribution Agreement for COPIKTRA® with Clinigen Healthcare Limited
- Clinigen Launches Malaysia Office to Strengthen Presence in Southeast Asia
- Sarepta Therapeutics and Clinigen Launch a Managed Access Program to Treat Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
- Clinigen’s role in global specialty pharmaceuticals
- Clinigen Group’s £225m acquisition of Idis supported by £106m in funding from Santander, RBS and HSBC
Artículos recopilados por Tamtam y conservados cuando tratan sobre la empresa, del más reciente al más antiguo. Cada uno enlaza con su fuente.
¿Vendes a empresas como Clinigen?
Tamtam encuentra las empresas que encajan con tu cliente ideal, investiga cada cuenta y te dice a quién contactar y cuándo.
Encontrar empresas similares